Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation

被引：1

作者：

Al Malki, Monzr M. ^{[1
]}

Vasu, Sumithira ^{[2
,3
]}

Modi, Dipenkumar ^{[4
]}

Perales, Miguel-Angel ^{[5
,6
]}

Ghoda, Lucy Y. ^{[7
,8
]}

Bui, Donna ^{[9
]}

Edavana, Vineetha ^{[10
]}

Lu, Emily ^{[10
]}

Kim, Sojung ^{[10
]}

Suarez, Lauren ^{[10
]}

Oelke, Mathias ^{[10
]}

Bednarik, Daniel ^{[10
]}

Knight, Robert D. ^{[11
]}

Varela, Juan C. ^{[12
,13
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA

[2] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH USA

[3] Comprehens Canc Ctr Columbus, Div Hematol, Dept Internal Med, Columbus, OH USA

[4] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Blood & Marrow Stem Cell Transplant Program, Detroit, MI USA

[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[7] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, 1500 E Duarte Rd, Duarte, CA 91010 USA

[8] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol Malignancies Translat Sci, Gehr Family Ctr Leukemia Res, Duarte, CA USA

[9] City Hope Natl Med Ctr, Duarte, CA USA

[10] NexImmune Inc, Gaithersburg, MD USA

[11] NexImmune Inc, Berkeley Hts, NJ USA

[12] Florida Hosp, Blood & Marrow Transplant Ctr, Winter Pk, FL USA

[13] Advent Hlth, Blood & Marrow Transplant Program, Orlando, FL USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-152419

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4819

引用

页数：5

共 50 条

[41] A PHASE I/II STUDY OF CHEMOTHERAPY FOLLOWED BY DONOR LYMPHOCYTE INFUSION PLUS INTERLEUKIN-2 FOR RELAPSED ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Inamoto, Y.
Fefer, A.
Sandmaier, B. M.
Gooley, T. A.
Warren, E. H.
Petersdorf, S. H.
Sanders, J. E.
Storb, R. F.
Appelbaum, F. R.
Martin, P. J.
Flowers, M. E. D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S339 - S339
[42] A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation
Inamoto, Yoshihiro
Fefer, Alexander
Sandmaier, Brenda M.
Gooley, Theodore A.
Warren, Edus H.
Petersdorf, Stephen H.
Sanders, Jean E.
Storb, Rainer F.
Appelbaum, Frederick R.
Martin, Paul J.
Flowers, Mary E. D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (09) : 1308 - 1315
[43] Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial
Baolin, Tang
Lee, Jongbok
Cheng, Siqi
Yao, Wen
Wang, Dongyao
Tu, Meijuan
Xiang, Zhiqiang
Geng, Liangquan
Wang, Mingxia
Qiang, Ping
Teng, Pingping
Sun, Guangyu
Pan, Tianzhong
Liu, Huilan
Yang, Liming
Sun, Zimin
Zhang, Li
Zhu, Xiaoyu
BLOOD, 2020, 136
[44] Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation
Cheng, Yifei
Chen, Yuhong
Yan, Chenhua
Wang, Yu
Zhao, Xiangyu
Chen, Yao
Han, Wei
Xu, Lanping
Zhang, Xiaohui
Liu, Kaiyan
Wang, Shasha
Chang, Lungji
Xiao, Lei
Huang, Xiaojun
ENGINEERING, 2019, 5 (01) : 150 - 155
[45] CD34+ lineage specific donor cell chimerism analysis for the diagnosis of minimal residual disease of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (HSCT)
Rosenow, F.
Berkemeier, A.
Silling, G.
Berdel, W. E.
Kienast, J.
Stelljes, M.
ONKOLOGIE, 2011, 34 : 229 - 229
[46] DRAMATIC REGRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA IN THE FIRST PATIENT TREATED WITH DONOR-DERIVED GENETICALLY-ENGINEERED ANTI-CD 19-CHIMERIC-ANTIGEN-RECEPTOR-EXPRESSING T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kochenderfer, J. N.
Dudley, M. E.
Maric, I
Feldman, S. A.
Salit, R.
Hardy, N. M.
Layton, P.
Blacklock-Schuver, B.
Wilder, J.
Devillier, L.
Gress, R. E.
Morgan, R. A.
Rosenberg, S. A.
Bishop, M. R.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S158 - S158
[47] A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Tu, Sanfang
Deng, Lan
Huang, Rui
Zhou, Xuan
Yang, Jilong
Zhou, Weijun
Li, Meifang
Yue, Chunyan
Wu, Shaojie
Guo, Zhenling
Chang, Lung-Ji
Li, Yuhua
BLOOD, 2018, 132
[48] Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study (vol 122, pg 2965, 2013)
Cruz, C. R. Y.
Micklethwaite, K. P.
Savoldo, B.
BLOOD, 2014, 123 (21) : 3364 - 3364
[49] In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation
Bollard, Catherine M.
Gottschalk, Stephen
Huls, M. Helen
Molldrem, Jeffrey
Przepiorka, Donna
Rooney, Cliona M.
Heslop, Helen E.
LEUKEMIA & LYMPHOMA, 2006, 47 (05) : 837 - 842
[50] Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation
Tan, Xu
Wang, Xiao-qi
Zhang, Cheng
Zhao, Xian-lan
Yao, Han
Chen, Guo
Ma, Ying-ying
Wen, Qin
Gao, Lei
Gao, Li
Kong, Pei-yan
Shen, Yan
Zhang, Xi
Lou, Shi-feng
CURRENT MEDICAL SCIENCE, 2023, 43 (04) : 733 - 740

← 1 2 3 4 5 →